Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

• François R. Girardin,
• Karen Cohen,
• Matthias Schwenkglenks,
• Matthias Schwenkglenks,
• Isabelle Durand-Zaleski

Affiliations

François R. Girardin

Division of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Faculty of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland

Karen Cohen

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa

Matthias Schwenkglenks

Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland

Matthias Schwenkglenks

Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, Zürich, Switzerland

Isabelle Durand-Zaleski

Université Paris Est Créteil, AP-HP URCEco Hôtel Dieu, Paris, France